---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-099239"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2026-08-20T20:19:00+00:00"
generated_at: "2026-08-20T20:20:10.327960+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Quoin shareholders approve NED compensation increase to $250k base retainer

## Summary
- Annual base retainer for non-employee directors increased to up to $250,000, set annually by Compensation Committee.
- Range for annual option awards raised to no less than $20,000 and no more than $200,000, at Compensation Committee discretion.
- All 7 director nominees re-elected; say-on-pay approved with 18,127,445 for votes.
- Shareholders approved 401(k) matching contribution changes and ratified CBIZ CPAs P.C. as auditor.
- Record date July 15, 2026: 70,294,615 ordinary shares outstanding; voting results include 16.3M broker non-votes.

## SEC filing metadata
- accession: 0001104659-26-099239
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2026-08-20T20:19:00+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/0001104659-26-099239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/tm2623719d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-099239
- JSON: https://secwatch.observer/filing/0001104659-26-099239.json
- Plain text: https://secwatch.observer/filing/0001104659-26-099239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.